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Background and purpose   One concern regarding resurfacing 
arthroplasty is the viability of the diminished femoral head and 
the postoperative risk of collapse, or a femoral neck fracture. 
18F-fluoride positron emission tomography (F-PET) enables 
us to assess bone viability despite there being a covering metal 
component. By F-PET studies, we recently showed the absence 
of metabolism in the remaining part of femoral heads, 1–4 years 
after surgery in 11 of 46 consecutive cases. We now present the 
further development of bone metabolism in these 11 cases. 
Patients and methods   10 patients (11 chips) with previously 
shown loss of femoral head metabolism were evaluated by radiog-
raphy and repeated F-PET scans, 3–6.5 years after surgery. The 
size of the area with low 18F-fluoride PET uptake in the femoral 
head was compared to that in earlier PET images.
Results   No patients had any clinical symptoms; nor was any 
necrotic bone area visible in plain radiographs. On F-PET scans, 
2 patients showed a diminished area with low uptake, 4 were 
unchanged, and 5 had enlarged areas. 
Interpretation   Bone metabolism surrounding a volume of 
bone with no metabolic activity changes dynamically even 5 years 
after surgery. The presence of bone with minor uptake of F-tracer, 
indicating low or no bone metabolism, with further progression in 
5 of 11 cases leads us to conclude that resurfacing THA should be 
used restrictively.

One concern with resurfacing arthroplasty of the hip is the 
viability of the diminished femoral head. During the surgical 
procedure, the blood supply to the remaining part of the head 
might be damaged (Howie et al. 1993, Nötzli et al. 2002, Stef-
fen et al. 2005, Khan et al. 2007). 
18F-fluoride positron emission tomography (F-PET) is a 
sensitive and non-invasive diagnostic method for analysis of 
bone metabolism (Grant et al. 2008) associated with new bone 
formation (Sörensen et al. 2003), and bone viability (Ullmark 
et al. 2007). Validation studies to correlate F-PET with bone 
histomorphometry have been performed (Messa et al. 1993, 
Piert et al. 2001).
In a previous prospective study of 14 patients (Ullmark et al. 
2009) who received an ASR resurfacing arthroplasty (DePuy 
Johnsson and Johnsson, Warsaw, IN), F-PET/CT scans were 
performed 1 week, 4 months, and 12 months after surgery. 
4 of these 14 patients were found to have lost bone metabo-
lism (measured by F-PET/CT) in the remaining part of their 
femoral heads, assessed as osteonecrosis, without any symp-
toms and without signs on plain radiographs. All 14 patients 
had had normal metabolism at the F-PET scan 1 week after 
surgery. Between the 4-month and the 12-month postopera-
tive PET scans, 4 of the 14 patients had developed an area 
with no metabolism. In another F-PET/CT study of 32 patients 
(Ullmark et al. 2011) with an ASR or DUROM resurfacing 
arthroplasty (Zimmer, Warsaw, IN), we performed the scans 
retrospectively 18–48 months after surgery. 7 cases in that 
study were found to have pathological non-metabolic areas in 
their femoral heads without there being symptoms or signs on 
radiographs.
For the 11 cases that had been found to have lost bone 
metabolism in these 2 previous studies (Ullmark et al. 2009, 
2011), we investigated how their bone metabolism had devel-
oped 3–6.5 years after surgery.
Patients and methods
The present study included patients who were previously 
shown to have developed areas without metabolism in their 
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11 patients (8 males), with a mean age of 45 (32–67) years at 
the time of surgery, were analyzed using plain radiography, 
clinical examination, and repeated F-PET scans. The mean 
follow-up time was 4.5 (3–6.5) years. 5 of the 11 cases were 
analyzed twice in this study, and 6 once, after their earlier 
scans (Table). 
PET analysis 
We used a Siemens/CTI Exact HR+ scanner (Siemens/CTI, 
Knoxville, TN) for the PET measurements. Patients were 
placed in the supine position on the camera bed. The legs were 
stabilized by using a vacuum cushion. A venous catheter was 
inserted in an antecubital or dorsal hand vein for injection of 
tracer. 40 min after intravenous injection of 150 MBq [18F]-
fluoride, a 15-cm section of the body covering the acetabulum 
and intertrochanteric region was scanned in 2D whole-body 
mode for 15 min. A 10-min transmission scan for attenua-
tion correction was performed after completing the emission 
acquisition. The CT image from the former study was co-reg-
istered and fused with the HR+ PET images to indicate exact 
anatomical locations in the analysis.
The quantitative emission scans were corrected for attenua-
tion, scatter, and decay and reconstructed by a process of itera-
tive reconstruction. Also, non-attenuation corrected emission 
scans were reconstructed. Standardized uptake values (SUVs) 
were calculated by the formula: SUV of tissue = activity in 
tissue (Bq/mL) × body weight (g) / total injected dose (Bq). 
Setting average body density to 1 g/mL, this expression gives 
a unit less value of the regional tissue activity in proportion to 
the average activity per mL for the entire body. 
The non-attenuation corrected images were evaluated quali-
tatively to rule out uptake artifacts related to motion. 
Quantitative 18F uptake in the 14 contralateral healthy femo-
ral heads, analyzed in coronal projection, of the patients in our 
earlier report (Ullmark et al. 2009) was mean 1.8 (0.80–3.41) 
SUV 1 year after surgery. In order to analyze the size of the 
region without normal metabolism in the femoral heads, we 
measured the area with an uptake of less than 0.65 SUV in 
the coronal projection of the hips, in the middle of the femo-
ral component. The low-uptake area included the prosthesis, 
cement, and low-uptake bone. We also performed a visual 
inspection of the scans. It was not possible to analyze the low-
uptake region as volume due to disturbance from the partial 
volume effect.
Results
The clinical results were good; they were unchanged in all 
patients compared to the previous reports (Ullmark et al. 2009, 
2011). None of the patients suffered from hip pain. 
Radiographic results
All implants were assessed to be stable, and unchanged from 
the plain radiographs taken postoperatively. 
PET results
All PET images clearly showed the fluoride uptake in the hip 
and upper femur, including the low-uptake areas. The area of 
low uptake corresponded to the acetabular and femoral pros-
thetic components, the bone cement, and most of the bone 
tissue region inside the femoral component (Figure 1). 
From the first PET scan to last one, the mean area of low 
uptake for all 11 cases had increased from 10.8 to 12.9 cm2 
(Table and Figure 2). 
Discussion
One of the main concerns after reintroduction of hip resurfac-
ing arthroplasties during recent years has been the viability of 
the femoral head. Until recently, it has not been possible to 
study bone metabolism under the metal femoral component 
of a resurfacing THA—but F-PET, in contrast to radiographic 
Figure 1. F-PET scan of a resurfaced hip. Low tracer uptake by 
prosthetic components, cement, and bone. The dotted red line indi-
cates area of low uptake (< 0.65 SUV), which appears black. 
Area of low uptake (< 0.65 SUV), given in cm2, in 11 hip joints con-
taining prosthetic components, cement, and bone without tracer 
uptake. Values in parenthesis denote time (in months) after surgery
Case  Age at surgery   PET 1  PET 2  PET 3
   1   35    8.9 (14)   11.3 (29)  13.9  (54)
   2   39    9.7 (12)  12.4 (22)  25.9  (38)
   3   58  17.6 (12)  10.3 (24)  13.1  (36)
   4   67    9.3 (12)  14.0 (24)  12.7  (36)
   5   43      9.5 (34)    9.6  (52)
   6   47  10.2 (34)  10.2 (57)  17.2  (79)
   7   56    14.8 (27)  14.5  (42)
   8   40      8.8 (27)    8.7  (41)
   9   51    14.3 (30)  10.2  (45)
   10   32      8.6 (63)    8.5  (77)
   11   32      7.1 (55)    7.2  (69)24  Acta Orthopaedica 2012; 83 (1): 22–25
methods, enables us to visualize the metabolism and viabil-
ity of bone in the remaining part of the head. The patients 
in the present study featured in one or other of 2 previous 
F-PET studies. In the prospective study (Ullmark et al. 2009), 
the volume of bone in the femoral heads that had reduced 
uptake of the F-tracer (indicating lack of new bone formation) 
appeared in the late postoperative time period, 4–12 months 
after surgery. This finding excludes the possibility of low-
uptake bone being spongious bone mixed with bone cement 
from the time of surgery. In our retrospective F-PET study of 
35 resurfacing THAs analyzed 2–5 years after surgery (Ull-
mark et al. 2011), 3 were clinical failures. In addition, 7 of the 
32 F-PET-scanned arthroplasties had areas of low uptake in 
the femoral heads bone, which were assessed as being loss of 
bone metabolism. In an F-PET study of 10 resurfacing THAs 
that were analyzed 10–33 months after surgery (Forrest et 
al. 2006), the metabolism in part of the head in 1 case had 
declined to half of the normal level. 
There have been reports of late failures with femoral neck 
fractures after resurfacing THA. Morlock et al. (2008) studied 
a large number of resurfacing revisions by means of histol-
ogy and morphology. They found that fractures involving the 
rim of the implant occurred during the first months, whereas 
fractures within the femoral head often took place closer to 1 
year after surgery. Campbell et al. (2006) also analyzed failed 
surface arthroplasties. They found that neck fractures occurred 
a few months after surgery, while failures from loosening of 
the femoral component often took place 17–100 months after 
surgery. Steffen et al. (2010) analyzed 2 groups of failed resur-
facing arthroplasties (failures from neck fractures and failures 
from other causes). The group with failure from neck fracture 
was found (to a higher degree) to be associated with osteo-
necrosis in the retrieved heads, compared to the group with 
failures for other reasons.
The 11 cases of resurfacing THA in this study, which all 
had areas of reduced bone metabolism, were all asymptom-
atic 3–6.5 years after surgery. There were still no signs of fail-
ure on plain radiographs. Surprisingly, in 5 of the cases the 
region of low uptake had become further enlarged, indicat-
ing progression. On 3 occasions, the area of low uptake had 
decreased from one PET scan to the next (Table), when a swift 
increase in uptake then ensued. This finding raises the interest-
ing question of whether the bone tissue without any detectable 
metabolism was actually in a state of necrosis, or whether the 
bone may have been in a state of chronic but reversible isch-
emia, indicating that healing of metabolically damaged bone 
may occur without any clinical consequences. 
The present study shows that relatively large metabolic 
changes can occur in the residual femoral head a long time after 
surgery in resurfacing THA. Apparently, the biology underly-
ing the F-PET-derived findings of absence of bone metabolism 
is diverse and includes the possibility of spontaneous heal-
ing. This is encouraging, and might lead to novel therapeu-
tic approaches if the mechanisms could be more thoroughly 
understood. Given the difficulties associated with obtaining 
histopathological material from asymptomatic patients, the 
use of PET with 18F-fluoride and other relevant tracers of bone 
activity in longitudinal studies should be explored further.
The long-term clinical implications of our findings are 
still unclear. However, the presence of regions without any 
metabolism in the femoral head adjoining the femoral compo-
nent, in combination with the observation that late failure in 
resurfacing arthroplasty can be due to femoral neck fracture, 
indicate that implant loosening in THA may be attributable 
to metabolic changes in bone. This leads us to the conclusion 
that resurfacing THA should be used with caution until the 
long-term outcomes of the procedure have been determined. 
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